Skip to main content
OpenTrials

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

346 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Completed

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

NCT05864846

Conditions
Behavior, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida Health - Department of Neurology Gainesville, Florida, United States
  • Nicklaus Children's Health, Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT04283669

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations
  • The University of Alabama at Birmingham (Site 700) Birmingham, Alabama, United States
  • Univ of California @ Los Angeles (Site 325) Los Angeles, California, United States
  • Children's National Medical Center (Site 775) Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta (Site 950) Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT05005845

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details
Completed

Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

NCT05626634

Conditions
Brain Diseases, CDKL5 deficiency disorder, Central Nervous System Diseases, +23 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rancho Los Amigos National Rehabilitation Center (RLANRC) Downey, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Northwest Florida Clinical Research Group Gulf Breeze, Florida, United States
View all 28 locations
View Trial Details

Related conditions